Hepatitis B Virus Infection is a Prognostic Biomarker for Better Survival in Operable Esophageal Cancer: Analysis of 2,004 Patients from an Endemic Area in China.

Jianyong ZouJunying ChenXuan XieZhengguo LiuXiaoli CaiQianwen LiuJing WenShuishen Zhang

Published in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2019)

Our large cohort study provided more definite and quantitative evidence that HBV infection is an independent favorable prognostic biomarker in patients with esophageal cancer, especially in patients with esophageal squamous cell carcinoma and advanced pathologic stage (III-IV).

Keyphrases

hepatitis b virus
neoadjuvant chemotherapy
high resolution
squamous cell carcinoma
liver failure
locally advanced
radiation therapy
free survival
lymph node